Beyond EGFR Inhibition: Multilateral Combat Strategies to Stop the Progression of Head and Neck Cancer

Experimental and Molecular Medicine - United States
doi 10.1038/s12276-018-0202-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Immune Checkpoint Inhibition in Head and Neck Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Treatment De-Intensification Strategies for Head and Neck Cancer

European Journal of Cancer
Cancer ResearchOncology
2016English

mTOR Co-Targeting Strategies for Head and Neck Cancer Therapy

Cancer and Metastasis Reviews
Cancer ResearchOncology
2017English

ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Lymphotoxin-Β Interacts With Methylated EGFR to Mediate Acquired Resistance to Cetuximab in Head and Neck Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View Beyond Cetuximab

Chemotherapy Research and Practice
2012English

Multiple Defects Sensitize P53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

FLUX: Responding to Head and Neck Cancer

CMAJ
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy